Dongsung Pharmaceutical Improvement Period Ends, Delisting Review Process Begins
- Dongsung Pharmaceutical's improvement period ended (May 13, 2026): delisting review process to proceed
- Deadline for submitting improvement plan implementation report: by May 22, 2026
- Korea Exchange to hold Corporate Review Committee within 20 business days after submission to decide on delisting
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Other Market Notice (End of Improvement Period and Guidance on Future Procedures)
- Company: Dongsung Pharmaceutical (002210)
- Submission: Securities Market Division
- Receipt: 05-13-2026
- Under KRX KOSPI Market Division